Upadacitinib for Refractory Behcet's Syndrome

Clinical trial NCT07080346 · COMPLETED

Trial details

NCT number: NCT07080346
Sponsor: Liu Tian
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Behcet Syndrome

Start date: 2024-01-25
Primary completion: 2024-12-20
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.